ALPHACAINE HYDROCHLORIDE Drug Patent Profile
When do Alphacaine Hydrochloride patents expire, and what generic alternatives are available?
Alphacaine Hydrochloride is a drug marketed by Carlisle and is included in three NDAs.
The generic ingredient in ALPHACAINE HYDROCHLORIDE is epinephrine; lidocaine hydrochloride. There are two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ALPHACAINE HYDROCHLORIDE?
- What are the global sales for ALPHACAINE HYDROCHLORIDE?
- What is Average Wholesale Price for ALPHACAINE HYDROCHLORIDE?
Summary for ALPHACAINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 4,348 |
| DailyMed Link: | ALPHACAINE HYDROCHLORIDE at DailyMed |
US Patents and Regulatory Information for ALPHACAINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Carlisle | ALPHACAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 084721-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Carlisle | ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE | epinephrine; lidocaine hydrochloride | INJECTABLE;INJECTION | 084720-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Carlisle | ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE | epinephrine; lidocaine hydrochloride | INJECTABLE;INJECTION | 084732-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
